Drug Shortage Report for MINT-TOPIRAMATE
Report ID | 28570 |
Drug Identification Number | 02315653 |
Brand name | MINT-TOPIRAMATE |
Common or Proper name | Mint- Topiramate |
Company Name | MINT PHARMACEUTICALS INC |
Market Status | MARKETED |
Active Ingredient(s) | TOPIRAMATE |
Strength(s) | 100MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | Bottles of 100 |
ATC code | N03AX |
ATC description | ANTIEPILEPTICS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-11-07 |
Estimated end date | 2017-12-15 |
Actual end date | 2017-12-15 |
Shortage status | Resolved |
Updated date | 2018-01-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 6575 DAVAND DRIVE MISSISSAUGA, ONTARIO CANADA L5T 2M3 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2017-11-07 | English | Compare |
v2 | 2017-11-07 | French | Compare |
v3 | 2017-11-08 | English | Compare |
v4 | 2017-12-15 | English | Compare |
v5 | 2017-12-15 | French | Compare |
v6 | 2018-01-04 | English | Compare |
v7 | 2018-01-04 | French | Compare |
Showing 1 to 7 of 7